Description
Creative Biolabs has developed several immune checkpoint stable cell Lines expressing the most popular immune checkpoints to accelerate clients' immunotherapy discovery and clinical translation. Recombinant CD33-CHO K1 cell line stably expressing the full length human C33/Siglec-3 receptor (GenBank Accession: BC028152.1). Which can be used in binding assays and functional assay.
Features
Stable cell lines for increased reliability and reproducibility;
Protein expression at the cell surface validated by FACS or WB;
Applications
• Screen for activators or inhibitors of antibody-mediated signaling for immunotherapy research and drug discovery.
• Characterize CD33 antibodies and ligands for binding assay.
Organism
Human
Strain Name
CHO-K1
Common Name
CD33
Background
CD33 belongs to the sialic acid-binding immunoglobulin (Ig)-like family. CD33 can be stimulated by sialic acid residues on glycoproteins or glycolipids, resulting in a signaling cascade that inhibits phagocytosis in cells and suppresses immune cell proliferation. CD33 overexpression is one of the top-ranked risk factors for Alzheimer's disease, and CD33 is the target of Gemtuzumab ozogamicin, an antibody- chemo drug conjugate for the treatment of patients with acute myeloid leukemia.

For Research Use Only | Not For Clinical Use

Online Inquiry
Related Products
Copyright © 2024 Creative Biolabs. All Rights Reserved.